Bone Growth Stimulators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

This report on the global bone growth stimulators market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global bone growth stimulators market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bone growth stimulators market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the bone growth stimulators market.

Secondary research also Incuded Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bone growth stimulators market.

The report Incudes an elaborate executive summary, along with a snapshot of the growth behavior of various segments Incuded in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global bone growth stimulators market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bone growth stimulators market.

The report delves into the competitive landscape of the global bone growth stimulators market. Key players operating in the global bone growth stimulators market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global bone growth stimulators market profiled in this report.

Research Methodology:

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market bone growth stimulators.

Secondary Research:

Secondary research Incudes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:

WorldWideScience.org
Elsevier, Inc
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service

Trade Data Sources:

Trade Map
UN Comtrade
Trade Atlas

Company Information:

OneSource Business Browser
Hoover’s
Factiva
Bloomberg

Mergers & Acquisitions:

Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research:

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

The publisher conducts primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis.

A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process Incude, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd
IBA Worldwide
Mevion Medical Systems, Inc

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with the publisher's 'Knowledge Repository', which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets.

A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology3. Executive Summary: Global Bone Growth Stimulators Market

4. Market Overview

4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bone Growth Stimulators Market Analysis and Forecast, 2017-2027

5. Market Outlook

5.1. Products Features/analysis
5.2. Regulatory Scenario by Region/globally
5.3. Reimbursement Scenario by Region/globally
5.4. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Bone Growth Stimulators Market Value and Forecast, by Product

6.1. Introduction
6.2. Global Bone Growth Stimulators Market Value Forecast, by Product, 2017-2027
6.2.1. Devices
6.2.1.1. External Devices
6.2.1.1.1. Combined Magnetic Field Devices
6.2.1.1.2. Capacitive Coupling Devices
6.2.1.1.3. Pulsed Electromagnetic Field Devices
6.2.1.1.4. Ultrasound Devices
6.2.1.2. Implantable Devices
6.2.2. Bone Morphogenetic Protein
6.2.3. Platelet-rich Plasma (PRP)
6.3. Global Bone Growth Stimulators Market Attractiveness Analysis, by Product

7. Global Bone Growth Stimulators Market Value and Forecast, by Application

7.1. Introduction
7.2. Global Bone Growth Stimulators Market Value Forecast, by Application, 2017-2027
7.2.1. Spinal Fusion Surgeries
7.2.2. Delayed Union & Nonunion Bone Fractures
7.2.3. Oral & Maxillofacial Surgeries
7.2.4. Others
7.3. Global Bone Growth Stimulators Market Attractiveness Analysis, by Application

8. Global Bone Growth Stimulators Market Value and Forecast, by End-user

8.1. Introduction
8.2. Global Bone Growth Stimulators Market Value Forecast, by End-user, 2017-2027
8.2.1. Hospitals & Clinics
8.2.2. Home Care
8.2.3. Academic & Research Institutes and CROs
8.3. Global Bone Growth Stimulators Market Attractiveness Analysis, by End-user

9. Global Bone Growth Stimulators Market Value and Forecast, by Region

9.1. Introduction
9.2. Bone Growth Stimulators Market Value Forecast, by Region, 2017-2027
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Bone Growth Stimulators Market Attractiveness Analysis, by Region

10. North America Bone Growth Stimulators Market Analysis and Forecast

10.1. Introduction
10.2. North America Bone Growth Stimulators Market Value Forecast, by Product, 2017-2027
10.2.1. Devices
10.2.1.1. External Devices
10.2.1.1.1. Combined Magnetic Field Devices
10.2.1.1.2. Capacitive Coupling Devices
10.2.1.1.3. Pulsed Electromagnetic Field Devices
10.2.1.1.4. Ultrasound Devices
10.2.1.2. Implantable Devices
10.2.2. Bone Morphogenetic Protein
10.2.3. Platelet-rich Plasma (PRP)
10.3. North America Bone Growth Stimulators Market Value Forecast, by Application, 2017-2027
10.3.1. Spinal Fusion Surgeries
10.3.2. Delayed Union & Nonunion Bone Fractures
10.3.3. Oral & Maxillofacial Surgeries
10.3.4. Others
10.4. North America Bone Growth Stimulators Market Value Forecast, by End-user, 2017-2027
10.4.1. Hospitals & Clinics
10.4.2. Home Care
10.4.3. Academic & Research Institutes and CROs
10.5. North America Bone Growth Stimulators Market Value Forecast, by Sub-region, 2017-2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Bone Growth Stimulators Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country

11. Europe Bone Growth Stimulators Market Analysis and Forecast

11.1. Introduction
11.2. Europe Bone Growth Stimulators Market Value Forecast, by Product, 2017-2027
11.2.1. Devices
11.2.1.1. External Devices
11.2.1.1.1. Combined Magnetic Field Devices
11.2.1.1.2. Capacitive Coupling Devices
11.2.1.1.3. Pulsed Electromagnetic Field Devices
11.2.1.1.4. Ultrasound Devices
11.2.1.2. Implantable Devices
11.2.2. Bone Morphogenetic Protein
11.2.3. Platelet-rich Plasma (PRP)
11.3. Europe Bone Growth Stimulators Market Value Forecast, by Application, 2017-2027
11.3.1. Spinal Fusion Surgeries
11.3.2. Delayed Union & Nonunion Bone Fractures
11.3.3. Oral & Maxillofacial Surgeries
11.3.4. Others
11.4. Europe Bone Growth Stimulators Market Value Forecast, by End-user, 2017-2027
11.4.1. Hospitals & Clinics
11.4.2. Home Care
11.4.3. Academic & Research Institutes and CROs
11.5. Europe Bone Growth Stimulators Market Value Forecast, by Country/Sub-region, 2017-2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Bone Growth Stimulators Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region

12. Asia Pacific Bone Growth Stimulators Market Analysis and Forecast

12.1. Introduction
12.2. Asia Pacific Bone Growth Stimulators Market Value Forecast, by Product, 2017-2027
12.2.1. Devices
12.2.1.1. External Devices
12.2.1.1.1. Combined Magnetic Field Devices
12.2.1.1.2. Capacitive Coupling Devices
12.2.1.1.3. Pulsed Electromagnetic Field Devices
12.2.1.1.4. Ultrasound Devices
12.2.1.2. Implantable Devices
12.2.2. Bone Morphogenetic Protein
12.2.3. Platelet-rich Plasma (PRP)
12.3. Asia Pacific Bone Growth Stimulators Market Value Forecast, by Application, 2017-2027
12.3.1. Spinal Fusion Surgeries
12.3.2. Delayed Union & Nonunion Bone Fractures
12.3.3. Oral & Maxillofacial Surgeries
12.3.4. Others
12.4. Asia Pacific Bone Growth Stimulators Market Value Forecast, by End-user, 2017-2027
12.4.1. Hospitals & Clinics
12.4.2. Home Care
12.4.3. Academic & Research Institutes and CROs
12.5. Asia Pacific Bone Growth Stimulators Market Value Forecast, by Country/Sub-region, 2017-2027
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Bone Growth Stimulators Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region

13. Latin America Bone Growth Stimulators Market Analysis and Forecast

13.1. Introduction
13.2. Latin America Bone Growth Stimulators Market Value Forecast, by Product, 2017-2027
13.2.1. Devices
13.2.1.1. External Devices
13.2.1.1.1. Combined Magnetic Field Devices
13.2.1.1.2. Capacitive Coupling Devices
13.2.1.1.3. Pulsed Electromagnetic Field Devices
13.2.1.1.4. Ultrasound Devices
13.2.1.2. Implantable Devices
13.2.2. Bone Morphogenetic Protein
13.2.3. Platelet-rich Plasma (PRP)
13.3. Latin America Bone Growth Stimulators Market Value Forecast, by Application, 2017-2027
13.3.1. Spinal Fusion Surgeries
13.3.2. Delayed Union & Nonunion Bone Fractures
13.3.3. Oral & Maxillofacial Surgeries
13.3.4. Others
13.4. Latin America Bone Growth Stimulators Market Value Forecast, by End-user, 2017-2027
13.4.1. Hospitals & Clinics
13.4.2. Home Care
13.4.3. Academic & Research Institutes and CROs
13.5. Latin America Bone Growth Stimulators Market Value Forecast, by Country/Sub-region, 2017-2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Bone Growth Stimulators Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region

14. Middle East & Africa Bone Growth Stimulators Market Analysis and Forecast

14.1. Introduction
14.2. Middle East & Africa Bone Growth Stimulators Market Value Forecast, by Product, 2017-2027
14.2.1. Devices
14.2.1.1. External Devices
14.2.1.1.1. Combined Magnetic Field Devices
14.2.1.1.2. Capacitive Coupling Devices
14.2.1.1.3. Pulsed Electromagnetic Field Devices
14.2.1.1.4. Ultrasound Devices
14.2.1.2. Implantable Devices
14.2.2. Bone Morphogenetic Protein
14.2.3. Platelet-rich Plasma (PRP)
14.3. Middle East & Africa Bone Growth Stimulators Market Value Forecast, by Application, 2017-2027
14.3.1. Spinal Fusion Surgeries
14.3.2. Delayed Union & Nonunion Bone Fractures
14.3.3. Oral & Maxillofacial Surgeries
14.3.4. Others
14.4. Middle East & Africa Bone Growth Stimulators Market Value Forecast, by End-user, 2017-2027
14.4.1. Hospitals & Clinics
14.4.2. Home Care
14.4.3. Academic & Research Institutes and CROs
14.5. Middle East & Africa Bone Growth Stimulators Market Value Forecast, by Country/Sub-region, 2017-2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Bone Growth Stimulators Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Zimmer Biomet
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Strategic Overview
15.2.2. Medtronic plc
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Financial Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Terumo Corporation
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Financial Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Bioventus, Inc.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Orthofix Medical, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Financial Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Strategic Overview
15.2.6. Ossatec Benelux BV
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Strategic Overview
15.2.7. BTT Health GmbH
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Financial Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Strategic Overview
15.2.8. Stimulate Health
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Strategic Overview